DelveInsight's analysis forecasts liver fibrosis market growth due to the introduction of emerging therapies, expecting an increase in market size during the study period (2020–2034). This anticipated ...

A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works ...

Researchers at the University of Oklahoma report a hormone, FGF21, may reverse fatty liver disease by signaling the brain.

A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

A new study published in the journal of BMC Gastroenterology showed that dementia risk was higher in patients with metabolic ...

A new study reveals that pregnant women with metabolic liver disease (MASLD) are significantly more likely to deliver ...

Early menopause before age 50 significantly increases the risk of fatty liver disease and metabolic disorders, according to ...

GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening ...

Liver diseases in children, often hereditary, present unique challenges, with conditions like biliary atresia, ...